Genenta Science S.p.A. (SAEN) stock
SAENNasdaqBiological Products, (No Diagnostic Substances)
$0.58+0.00 (+0.85%)
Close on Nov 18, 2026Market cap $13.64MP/E –Yield –
Genenta Science S.p.A. operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was -€6.60M. The highest annual figure on record is -€4.62M in fiscal 2019.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -€6.60M | – |
| FY2024 | Dec 31, 2024 | -€9.76M | – |
| FY2023 | Dec 31, 2023 | -€11.73M | – |
| FY2022 | Dec 31, 2022 | -€11.04M | – |
| FY2021 | Dec 31, 2021 | -€5.69M | – |
| FY2020 | Dec 31, 2020 | -€5.59M | – |
| FY2019 | Dec 31, 2019 | -€4.62M | – |
See a number that looks wrong?